alimatravir
offering product urn:matchory:offering:01m772jz6wfsvvqm6zpmkp0z2r
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: makes. Commodity: 51342500 Antiviral nucleosides (class).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Relation of the owner to it relation | makes | extraction extract 3 | alimatravir, an investigational, novel, once-monthly oral pill as pre-exposure prophylaxis (PrEP) for the prevention of HIV-1https://www.merck.com/wp-content/uploads/sites/124/2026/08/PurposeforProgressMerckImpactReport2025-2026.pdf |
2026-11-12 | current |
| Name as stated name | alimatravir | products products 2 | alimatravirhttps://www.merck.com/research/product-pipeline/ |
2026-11-12 | current |
| Name as stated name | alimatravir | extraction extract 3 | alimatravirhttps://www.merck.com/research/product-pipeline/ |
2026-11-12 | current |
| UNSPSC classification unspsc | 51342500 (16 candidates considered) (0.75) | classification unspsc 3 | 2026-11-12 | current |